No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PTGX Protagonist Therapeutics
- 34.590
- -0.610-1.73%
Close Jul 2 16:00 ET
2.03BMarket Cap13.62P/E (TTM)
35.900High34.310Low12.66MVolume35.610Open35.200Pre Close438.67MTurnover29.41%Turnover RatioLossP/E (Static)58.65MShares35.96052wk High3.62P/B1.49BFloat Cap13.72052wk Low--Dividend TTM43.07MShs Float50.540Historical High--Div YieldTTM4.52%Amplitude4.470Historical Low34.641Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Nike, Kura Sushi Fall; Infinera, Protagonist Therapeutics Rise, Friday, 6/28/2024
Market-Moving News for June 28th
PTGX: 11% | Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3DJT: 16% | Trump Media & Technology Group shares are trading higher following Thursday's p
Express News | Protagonist Therapeutics Shares Are Trading Higher After It Was Announced the Company Will Join the S&P SmallCap 600
Protagonist Therapeutics Set to Join S&P SmallCap 600
Express News | Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3
Is Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
Comments
Despite a growing cash burn rate, other factors hint at the company's promising trajectory. With a sensible cash runway and a low cash burn to market cap ratio, securing more funds for expansion shouldn't be an issue.
Companies Like Protagonist Therapeutics (NASDAQ:PTGX) Are In A Position To Invest In Growth
$Protagonist Therapeutics(PTGX.US$ what the hell is going on?
1
$Protagonist Therapeutics(PTGX.US$ What’s with the crash?
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg